2021 annual financial data
Enliven Therapeutics 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -24,762,000 USD and net income was -24,740,000 USD.
Operating cash flow was -19,134,000 USD.
Get free Enliven Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -24,762,000 USD
- Net income
- -24,740,000 USD
- Operating cash flow
- -19,134,000 USD